Fig. 7From: TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerCorrelation between tumor immune-checkpoint and risk score. A Comparison of the immune-checkpoint genes in the high- and low-risk groups. B–K Spearman correlation analysis between immune-checkpoint molecules and risk scoreBack to article page